Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial Read More > May 1, 2021
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice Read More > April 27, 2021
Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression Read More > March 29, 2021
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes Read More > March 23, 2021
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action Read More > March 19, 2021
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review Read More > March 7, 2021
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property Read More > February 26, 2021
Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment-resistant depression Read More > February 21, 2021
Single, Fixed-Dose Intranasal Ketamine for Alleviation of Acute Suicidal Ideation. An Emergency Department, Trans-Diagnostic Approach: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial Read More > February 14, 2021
